Medovex Corp Stock Debt To Equity
Medovex Corp fundamentals help investors to digest information that contributes to Medovex Corp's financial success or failures. It also enables traders to predict the movement of Medovex OTC Stock. The fundamental analysis module provides a way to measure Medovex Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medovex Corp otc stock.
Medovex |
Medovex Corp OTC Stock Debt To Equity Analysis
Medovex Corp's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Medovex Corp Debt To Equity | 2.61 % |
Most of Medovex Corp's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medovex Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
CompetitionAccording to the company disclosure, Medovex Corp has a Debt To Equity of 2.609%. This is 95.13% lower than that of the Healthcare sector and 86.52% lower than that of the Biotechnology industry. The debt to equity for all United States stocks is 94.64% higher than that of the company.
Medovex Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medovex Corp's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Medovex Corp could also be used in its relative valuation, which is a method of valuing Medovex Corp by comparing valuation metrics of similar companies.Medovex Corp is currently under evaluation in debt to equity category among its peers.
Medovex Fundamentals
Return On Equity | -4.6 | |||
Return On Asset | -3.48 | |||
Operating Margin | (3.51) % | |||
Current Valuation | 8.88 M | |||
Shares Outstanding | 477.61 K | |||
Shares Owned By Insiders | 25.51 % | |||
Number Of Shares Shorted | 294 | |||
Price To Earning | (1.53) X | |||
Price To Book | 34.90 X | |||
Price To Sales | 3.68 X | |||
Revenue | 1.61 M | |||
Gross Profit | 906.81 K | |||
EBITDA | (4.61 M) | |||
Net Income | (4.8 M) | |||
Cash And Equivalents | 45.88 K | |||
Cash Per Share | 0.16 X | |||
Total Debt | 3.88 M | |||
Debt To Equity | 2.61 % | |||
Current Ratio | 0.04 X | |||
Book Value Per Share | (17.98) X | |||
Cash Flow From Operations | (4.81 M) | |||
Short Ratio | 3.47 X | |||
Earnings Per Share | (0.05) X | |||
Target Price | 1.75 | |||
Beta | 0.73 | |||
Market Capitalization | 1.06 M | |||
Total Asset | 321.4 K | |||
Retained Earnings | (38.35 M) | |||
Working Capital | 3.33 M | |||
Current Asset | 4.18 M | |||
Current Liabilities | 851.22 K | |||
Net Asset | 321.4 K |
Thematic Opportunities
Explore Investment Opportunities
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in Medovex OTC Stock
If you are still planning to invest in Medovex Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medovex Corp's history and understand the potential risks before investing.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |